Please login to the form below

lenalidomide

This page shows the latest lenalidomide news and features for those working in and with pharma, biotech and healthcare.

BMS isn’t phased by Opdivo’s slowing growth – for now

over Celgene’s top-seller Revlimid (lenalidomide), which accounts for almost two-thirds of its sales but is facing the threat of generic competition in the coming years.

Latest news

Dragonfly signs Celgene as partner for NK cell platform

Celgene has been signing a string of research partnerships and licensing deals in the last couple of years to diversify its portfolio and reduce its reliance on Revlimid (lenalidomide), a drug
ASH18: CAR-T and drugs give new options for multiple myeloma

Ninlaro is already approved as a second-line therapy in combination with Celgene’s Revlimid (lenalidomide) and dexamethasone, and Takeda is also trying to move its drug into the first-line
FDA green lights BMS’ multiple myeloma combo

A recent phase 2 study, ELOQUENT-3, tested the combination in multiple myeloma patients who received two or more prior therapies, and were either refractory or relapsed and refractory to lenalidomide
FDA clears first-line use for J&J’s myeloma drug Darzalex

Later on, additional studies of Darzalex as an add-on to regimens based on Celgene’s Revlimid (lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated
Celgene to launch five new products through to 2020

The statements came as Celgene reported expectation-topping sales and earnings driven by Revlimid (lenalidomide) and new psoriasis therapy Otezla (apremilast).

More from news
Approximately 14 fully matching, plus 82 partially matching documents found.

Latest Intelligence

Building a business that is lean and specialised

drug Revlimid (lenalidomide).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Planner – Healthcare Advertising – New Role: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Account Director, Healthcare Marketing Agency: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Account Director, Medical Education: Salary TBC

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Senior Medical Writer: Up to £50, 000 with Benefits

Project Manager/ Account Manager: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Medical Writer: Great salary and benefits

Digital Account Director: Salary TBC

Senior Medical Writer: Salary TBC

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The importance of co-creation with patients: Overcoming the barriers...
Three billboards on the road to multichannel: Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence: Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....